AOD 9604

AOD 9604 is a modified fragment of the human growth hormone (HGH) molecule, specifically designed to promote fat loss and improve metabolic function. This peptide has gained attention in research for its potential applications in weight management, fat reduction, and the treatment of metabolic disorders. Unlike other HGH derivatives, AOD 9604 does not affect growth or increase muscle mass but specifically targets fat-burning pathways in the body.

AOD 9604 works by mimicking the fat-burning effects of HGH without stimulating other growth-related processes. It functions by binding to the same receptors as HGH, promoting the breakdown of fat through lipolysis and preventing the accumulation of new fat cells. Researchers have been investigating AOD 9604 for its ability to reduce visceral fat, improve fat distribution, and its potential applications in obesity treatment, metabolic syndrome, and related disorders.

The 10mg vial of AOD 9604 is ideal for researchers beginning studies on fat metabolism, weight management, and metabolic regulation. This vial size is suitable for in vitro studies, receptor binding assays, and initial in vivo experiments in animal models. It provides enough material for focused research without requiring larger quantities, offering a practical solution for early-phase studies.

Progression Peptides offers AOD 9604 as a high-purity lyophilized powder with third-party purity verification, ensuring consistency and reliability in research. The lyophilized form preserves the peptide’s stability and bioactivity when stored and handled according to recommended guidelines.

Reconstitution: Reconstitute with bacteriostatic water, allowing it to dissolve gently without shaking. The solution should remain clear and free from visible particles.

Storage: Store the lyophilized peptide at -20°C. Once reconstituted, refrigerate at 2-8°C and use within 30 days.

For research purposes only. Not for human consumption or veterinary use. Sold exclusively for laboratory and in vitro research.